Air Liquide has announced the acquisition of BiotechMarine by its subsidiary Seppic. BiotechMarine is a leading player in the design and marketing of active ingredients for the global cosmetics industry.
A subsidiary of the Roullier Group, BiotechMarine is a company that specialises in the design and marketing of bio-based, cosmetic active ingredients made from algae. BiotechMarine is based in the west of France, in the town of Pontrieux, and has 35 employees.
The acquisition of BiotechMarine will provide Seppic, a subsidiary in Air Liquide's Healthcare Business Line, with complementary expertise in marine biotechnologies and plant cell culture.
Pascal Vinet, vice president, Healthcare Global Operations and member of the Group’s Executive Committee, commented: "We are delighted to welcome these new employees to the group. With this acquisition Air Liquide intends to reinforce its position in the field of healthcare specialty ingredients. The complementarity of BiotechMarine and Seppic allows us to widen our knowhow and continue the development of this activity. Health is one of the group's growth drivers."
